2024
1. Yamaguchi S, Minamide N, Imai H, Ikeda T, Watanabe M, Imanaka-Yoshida K, Maruyama K. The development of early human lymphatic vessels as characterized by lymphatic endothelial markers EMBO J. 2024 Feb 14. doi: 10.1038/s44318-024-00045-0. Online ahead of print.
2. Takeuchi Y, Wang Y, Sasaki K, Sato O, Tsuchikawa T, Wang L, Amaishi Y, Okamoto S, Mineno J, Hirokawa Y, Hatanaka KC, Hatanaka Y, Kato T, Shiku H, Hirano S. Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model. Biomed Pharmacother. 170:116052, 2024.
3. Yamashita D, Fujimoto N, Okado R, Ikami A, Yamamoto A, Tono Y, Watanabe K, Hayashi A, Ota S, Mizutani M, Kitamura, T, Dohi K. Cardiac Angiosarcoma with Pulmonary and Adrenal Metastases Diagnosed by FDG-PET/CT-guided Adrenal Biopsy. J Cardiol Cases. 2024 in press.
2023
1. Matsuda C, Ishii K, Nakagawa Y, Shirai T, Sasaki T, Hirokawa YS, Iguchi K, Watanabe M. Fibroblast-derived exosomal microRNA regulates NKX3-1 expression in androgen-sensitive, androgen receptor-dependent prostate cancer cells. J Cell Biochem. 2023 Jun 19. doi: 10.1002/jcb.30435.
2. Watanabe M, Liang R, Usugi E, Hayashi A, Hirokawa Y, Sobti RC. Recent advances of iron oxide nanoparticles-based nano medicine for prostate cancer (review). In Molecular Biomarkers for Cancer Diagnosis and therapy edited by RC Sobti, H Sugimura and A Sobti. Springer Verlag, Singapore.
3. Sobti RC, Dhalla NS, Watanabe M, Sobti A. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications. Springer Nature, Singapore. 2021. https://doi.org/10.1007/978-981-16-5105-2
4. Watanabe M, Usugi E, Usui M, Hayashi A, Hirokawa Y, Sobti RC. Autopsy and COVID-19. In Role of Microbes in Sustainable Development: Human Health and Diseases edited by RC Sobti, RC Kuhad and Lal R. Springer Verlag, Singapore. In press
5. Katsurahara M, Umeda Y, Yukimoto H, Shigefuku A, Nakamura M, Hamada Y, Tanaka K, Horiki N, Hayashi A, Nakagawa H. Gastrointestinal: Small bowel hemangioma with unusual endoscopic findings and complicated with obscure gastrointestinal bleeding. J Gastroenterol Hepatol. 2023 Sep;38(9):1455. doi: 10.1111/jgh.16109.
6. 腫瘍病理鑑別診断アトラス 前立腺癌 第2版 渡邉昌俊・都築豊徳 編集 文光堂 2023
7. Kanayama K, Hirokawa YS. Molecular biomarkers in gastric cancer. In Biomarkers in Cancer Detection and Monitoring of Therapeutics Volume 2: Diagnostic and Therapeutic Applications edited by Sobti RC, Watanabe M, Sobti S. Academic Press, 2023.
8. Tsuboi J, Yamada R, Hirokawa YS. Molecular biomarkers in pancreatic ductal adenocarcinoma. In Biomarkers in Cancer Detection and Monitoring of Therapeutics Volume 2: Diagnostic and Therapeutic Applications edited by Sobti RC, Watanabe M, Sobti S. Academic Press, 2023.
9. Semba R, Uchida K. Molecular biomarkers in prostate cancer. In Biomarkers in Cancer Detection and Monitoring of Therapeutics Volume 2: Diagnostic and Therapeutic Applications edited by Sobti RC, Watanabe M, Sobti S. Academic Press, 2023.
10. Semba R, Uchida K, Hirokawa Y, Shiraishi T, Onishi T, Sasaki T, Inoue T, Watanabe M. Short-term prognosis of low-risk prostate cancer patients is favorable despite the presence of pathological prognostic factors: a retrospective study BMC Urol. Oct 31;23(1):174. 2023
11. 野村宣徳, 内田克典. 腫瘍病理鑑別アトラス 腎盂・尿管・膀胱癌 第2版, 第2部I-1. 尿路上皮内癌, 第3部I. 尿路腫瘍の診断に有用な免疫染色. p26-31, p142-146, 2023.
12. 野村宣徳, 内田克典. 【病理診断クイックリファレンス 2023】精子肉芽腫, 男性生殖器リンパ腫, 腺腫様腫瘍. 病理と臨床, 41(臨増). p181, 186-187. 2023.
13. 野村宣徳, 内田克典. 非腫瘍性疾患病理アトラス 肝胆膵, Ⅱ. F. 胆嚢炎, p214-223, 2023.
14. Otsuka Y, Tanizaki R, Nomura Y. Leukocytoclastic Vasculitis Secondary to Severe Fever with Thrombocytopenia Syndrome. Intern Med. Published online October 6, 2023. doi:10.2169/internalmedicine.2504-23
15. Sobti RC, et al. Role of Microbes in Sustainable Development: Human Health and Diseases. p677–693. Autopsy and COVID-19. Watanabe M, Usugi E, Usui M, Hayashi A, Hirokawa Y, Sobti RC. Springer, 2023.
16. Nishimura M, Nakanishi T, Ichishi M, Matsushima Y, Watanabe M, Yamanaka K. Increased Mortality Risk at Septic Condition in Inflammatory Skin Disorders and the Effect of High-Fat Diet Consumption. Int J Mol Sci, 25(1), 478, 2023.
17. Kobayashi H, Ueda K, Morimoto S, Ishikawa M, Leventoux N, Sasaki R, Hirokawa Y, Kokubo Y, Okano H. Protein profiling of extracellular vesicles from iPSC-derived astrocytes of patients with ALS/PDC in Kii peninsula. Neurol Sci. 44(12):4511-4516, 2023.
18. Qi C, Verheijen BM, Kokubo Y, Shi Y, Tetter S, Murzin AG, Nakahara A, Morimoto S, Vermulst M, Sasaki R, Aronica E, Hirokawa Y, Oyanagi K, Kakita A, Ryskeldi-Falcon B, Yoshida M, Hasegawa M, Scheres SHW, Goedert M. Tau filaments from amyotrophic lateral sclerosis/parkinsonism-dementia complex adopt the CTE fold Proc Natl Acad Sci U S A. 120(51):e2306767120, 2023.
2022
1. Watanabe S, Kondo M, Ichishi M, Hayashi A, Matsushima Y, Hirokawa Y, Habe K, Yamanaka K. Eosinophilic fasciitis induced by a game of drumming probably via type 2 innate immunity. Int J Rheum Dis. 2022 Jan 13. doi: 10.1111/1756-185X.14284.
2. 渡邉昌俊. 若手病理医のためのキャリアパス講座[4] 病理から境界領域へ-医工連携への招待. 病理と臨床, 40(3), 287-292. 2022.
3. Mizutani K, Ikeda S, Ichishi M, Nakanishi T, Okada K, Umaoka A, Kondo M, Habe K, Watanabe M, Yamanaka K. Severe skin inflammation leads to salivary gland atrophy and dysfunction. J Dermatol, Jun;49(6):642-647, 2022.
4. Tsunoda A, Mizuno T, Iida S, Uchida K, Yamashita M, Sukeno K, Oka H, Tono Y, Ishihara M, Saito K, Tamaru S, Yamanaka K, Tawara I.Atezolizumab-Induced Sarcoidosis-Like Reaction in a Patient with Metastatic Breast Cancer. Case Rep Oncol Med. 2022 Jan 27;2022:2709062. doi: 10.1155/2022/2709062.
5. Noro A, Ishitobi M, Hanamura N, Kashikura Y, Yamashita M, Kozuka Y, Saito K, Mizuno T, Ogawa T. A Case of Metaplastic Squamous Cell Carcinoma of the Breast that Showed a Pathological Complete Response After Neoadjuvant Chemotherapy with Weekly Paclitaxel. Am J Case Rep. 2022 Jan 12;23:e935035. doi:10.12659/AJCR.935035.
6. Amemiya T, Shibata K, Takahashi J, Watanabe M, Nakata S, Nakamura K, Yamaguchi T. Glycolytic oscillations in Hela cervical cancer cell spheroids. FEBS J., accepted.
7. Eguchi A, Iwasa M, Yamada M, Tamai Y, Shigefuku R, Hasegawa H, Hirokawa Y, Hayashi A, Okuno K, Matsushita Y, Nakatsuka T, Enooku K, Sakaguchi K, Kobayashi Y, Yamaguchi T, Watanabe M, Takei Y, Nakagawa H. A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human NASH. Hepatology Communication, 2022. 00:1-13.
8. Iida S, Nakanishi T, Momose F, Ichihi M, Mizutani K, Matsushima Y, Umaoka A, Kondo M, Habe K, Hirokawa Y, Watanabe M, Iwakura Y, Miyahara Y, Imai Y, Yamanaka K. IL-17A is the critical cytokine for liver and spleen amyloidosis in inflammatory skin disease. Int. J. Mol. Sci. 2022, 23, 5726.
9. Ishii K, Sugimura Y, Watanabe M. Drug Repositioning of the Phenylpiperazine Derivative Naftopidil in Prostate Cancer Treatment. In: Sobti R, Dhalla N.S. (eds) Biomedical Translational Research. Springer, Singapore. 2022. https://doi.org/10.1007/978-981-16-9232-1_8
10. Higashi S, Sasaki T, Uchida K, Kageyama T, Ikejiri M, Matsumoto R, Kato M, Masui S, Yoshio Y, Nishikawa K, Okugawa Y, Watanabe M, Inoue T.Succinate dehydrogenase B-deficient renal cell carcinoma with a germline variant in a Japanese patient: a case report. Hum Genome Var. 2022 Jul 22;9(1):25. doi: 10.1038/s41439-022-00202-z.
11. Nishimura M, Kondo M, Habe K, Hayashi A, Yamanaka K. Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris. Clin Case Rep. 2022 Oct 7;10(10):e6413. doi: 10.1002/ccr3.6413.
12. Gyoten K, Kuriyama N, Hayashi A, Kobayashi Y, Kobayashi I, Hayasaki A, Tanemura A, Murata Y, Kishiwada M, Mizuno S. Biliary obstruction caused by plant seeds. Clin J Gastroenterol. 2022 Oct 5. doi: 10.1007/s12328-022-01712-7.
13. Yamakawa D, Tsuboi J, Kasahara K, Matsuda C, Nishimura Y, Kodama T, Katayama N, Watanabe M, Inagaki M. Cilia-Mediated Insulin/Akt and ST2/JNK Signaling Pathways Regulate the Recovery of Muscle Injury. Adv Sci (Weinh). 2022 Nov 14:e2202632. doi: 10.1002/advs.202202632. Epub ahead of print.
2021
1. Ishii K, Nakagawa Y, Matsuda C, Katoh D, Ichishi M, Shirai T, Hirokawa Y, Fujiwara M, Sugimura Y, Watanabe M. Heterogeneous induction of an invasive phenotype in prostate cancer cells by coculturing with patient-derived fibroblasts. J Cell Biochem, 122(1), 1-10, 2021.
2. Totsuka Y, Watanabe M, Lin Y. New horizons of DNA adductor for exploring environmental causes of cancer. Cancer Sci, 112(1), 7-15, 2021.
3. Kim Y, Park JB, Fukuda J, Watanabe M, Chun YS. The effect of neddylation blockade on slug-dependent cancer cell migration is regulated by p53 mutation Status. Cancers, 13, 531, 2021.
4. Yamakawa D, Katoh D, Kasahara K, Shiromizu T, Matsuyama M, Matsuda C, Maeno Y, Watanabe M, Nishimura Y, Inagaki M. Primary cilia dependent-lipid rafts, caveolin dynamics regulate adipogenesis. Cell Rep., 34(10), 108817, 2021.
5. Sugioka K, Hayashi A, Ichishi M, Sygimoto Y, Habe K, Yamanaka K. Three case of lymphocytic infiltration of the eyelid. Dermatopathology. 8(2):124-129. 2021.
6. Hamada Y, Eguchi A, Tanaka K, Katsurahara M, Horiki N, Nakamura M, Tenpaku M, Iwasa M, Ichishi M, Watanabe M, Takei Y. Plexin domain containing protein 2 is more expressed within the invasive area of human colorectal cancer tissues. Hum Cell. 2021 Jun 19. doi: 10.1007/s13577-021-00570-8.
7. Amemiya T, Shibata K, Watanabe M, Nakata S, Nakamura K, Yamaguchi T. “Glycolytic oscillations in cancer cells”, McClintock P. and Stefanovska A. Eds. in Physics of Biological Oscillations, New Insights into Non-Equilibrium and Non-Autonomous Systems, Springer, pp245-239, 2021.
8. Nishimura Y, Yamakawa D, Uchida K, Shiromizu T, Watanabe M, Inagaki M. Primary cilia and lipid raft dynamics. Open Biol. Aug;11(8):210130. 2021.
9. Hirokawa YS, Iwata T, Okugawa Y, Tanaka K, Sakurai H, Watanabe M. HER2-positive adenocarcinoma arising from heterotopic pancreas tissue in the duodenum: A case report. World J Gastroenterol. Jul 28;27(28):4738-4745. 2021
10. Inoue C, Nishihama K, Hayasaki A, Okano Y, Hayashi A, Eguchi K, Uemura M, Suzuki T, Yasuma T, Inoue T, Yorifuji T, Mizuno S, Gabazza EC, Yano Y. Case Report: A Difficult-to-Diagnose Case of Hyperinsulinemic Hypoglycemia Surgically Treated After Developing Acute Pancreatitis. Front Endocrinol. 2021 Oct 27;12:731071. doi: 10.3389/fendo.2021.731071.
11. Delineating Health and Health System: Mechanistic Insights into Covid19 Complications. Editors R. C. Sobti, Naranjan S. Dhalla, Masatoshi Watanabe, Aastha Sobti. Springer, Singapore 2021.
12. Nishimura Y, Yamakawa D, Uchida K, Shiromizu T, Watanabe M, Inagaki M. Primary cilia and lipid raft dynamics. Open Biol. 2021 Aug;11(8):210130. doi: 10.1098/rsob.210130.
13. Komine R, Kojima M, Ishi G, Kudo M, Sugimoto M, Kobayashi S, Takahashi S, Konishi M, Kobayashi T, Akimoto T, Murakami A, Sasaki M, Tanaka M, Matsuzaki A, Ohike N, Uchida K, Sugiyama T, Hirabayashi K, Tajiri T, Ishida K, Kai K, Omori Y, Notohara K, Yamaguchi H, Matsuda Y, Naito Y, Fukumura Y, Hamada Y, Mihara Y, Masugi Y, Gotohda N, Harada K, Fukushima N, Furukawa T. Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable origin. Cancer Med. 2021 Jun;10(11):3499-3510. doi: 10.1002/cam4.3809.
14. Owa S, Sasaki T, Uchida K, Watanabe S, Kato M, Sugino Y, Kato M, Masui S, Nishikawa K, Yoshio Y, Kanda H, Sugimura Y, Inoue T. A case of adenocarcinoma of the rete testis with durable response to cisplatin-based chemotherapy. IJU Case Rep. 2021 Jun 19;4(5):267-271. doi: 10.1002/iju5.12298.
15. Murata Y, Mizuno S, Kishiwada M, Uchida K, Noguchi D, Gyoten K, Hayasaki A, Fujii T, Iizawa Y, Tanemura A, Kuriyama N, Sakurai H, Isaji S. Clinical significance and predictors of complete or near-complete histological response to preoperative chemoradiotherapy in patients with localized pancreatic ductal adenocarcinoma. Pancreatology. 2021 Dec;21(8):1482-1490. doi: 10.1016/j.pan.2021.08.011.
16. 稲葉草太, 佐々木豪, 服部優奈, 寺邊隆史, 加藤桃子, 東真一郎, 加藤学, 舛井覚, 吉尾裕子, 西川晃平, 早崎碧泉, 山中隆嗣, 内田克典, 井上貴博. 術前アキシチニブ・ペムブロリズマブ併用療法が有効であった下大静脈腫瘍塞栓を伴う淡明細胞型腎癌の1例. 泌尿器科紀要, 67(10), p443-447, 2021.
17. 石神瑛亮, 小林正佳, 西田幸平, 森下裕之, 内田克典, 豊増泰, 竹内万彦. 鼻副鼻腔未分化癌の検討. 日鼻誌, 60(2), p159-169, 2021.
18. 仙波玲美, 内田克典. 【治療方針を変える病理所見 診療ガイドラインと治療戦略】(第1部)臓器別 前立腺. 病理と臨床, 39(臨増). p239-248. 2021.
19. 仙波玲美, 内田克典. 精巣腫瘍病理アトラス 第2部Ⅷ. 傍精巣組織の腫瘍. 2021.
20. Arase S, Arima K, Kusafuka T, Kanamori Y, Katou H, Imai H, Koyama T, Inoue T. Rare case of retropubic parasymphyseal cyst in a male patient. IJU Case Rep. 2021 Oct 7;5(1):36-40. doi: 10.1002/iju5.12382.
21. Bishop JA, Nakaguro M, Whaley RD, Ogura K, Imai H, Laklouk I, Faquin WC, Sadow PM, Gagan J, Nagao T. Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations. Histopathology. 2021 Sep;79(3):338-346. doi: 10.1111/his.14296.
22. Kashima E, Nakano E, Watanabe Y, Imai H, Oka K, Kageyama S, Tanaka I. Acute Megakaryoblastic Leukemia Harboring a Subclone Expressing BCR-ABL1 Fusion Gene Product. Intern Med. 2021 Nov 15;60(22):3609-3614. doi: 10.2169/internalmedicine.7335-21.
23. Nato Y, Miyazaki K, Imai H, Nakano E, Kageyama Y, Ino K, Fujieda A, Matsumoto T, Tawara I, Tanaka K, Yamaguchi M, Katayama N. Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantation. Int J Hematol. 2021 Jul;114(1):129-135. doi: 10.1007/s12185-021-03107-9.
24. Ueo H, Ueo H, Minoura I, Gamachi A, Doi T, Yamaguchi M, Yamashita T, Tsuda H, Moriya T, Yamaguchi R, Kozuka Y, Sasaki T, Masuda T, Kai Y, Kubota Y, Urano Y,
Mori M, Mimori K. Clinical usefulness of a novel fluorescence technique for the intraoperative diagnosis of surgical margins in patients with breast cancer. Br J Surg. 2021 Oct 23;108(10):e340-e342. doi: 10.1093/bjs/znab265.
25. Nishiguchi Y, Matsuyama H, Shindo A, Matsuura K, Niwa A, Hirota Y, Fukuma T, Ito H, Kozuka Y, Tomimoto H. Cerebral Embolism Associated with Calcified Amorphous Tumor: A Review of Cerebral Infarction Cases. Intern Med. 2021 Jul 15;60(14):2315-2319. doi: 10.2169/internalmedicine.6262-20.
26. Nagano M, Saito K, Kozuka Y, Ichishi M, Yuasa H, Noro A, Imai N, Shibusawa M, Kimoto M, Ishitobi M, Tono Y, Oda H, Ishihara M, Mizuno T, Ogawa T, Katayama N. CD204-positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand-1 expression. Oncol Lett. 2021 Jan;21(1):36. doi: 10.3892/ol.2020.12297.
27. Kawada JI, Takeuchi S, Imai H, Okumura T, Horiba K, Suzuki T, Torii Y, Yasuda K, Imanaka-Yoshida K, Ito Y. Immune cell infiltration landscapes in pediatric acute myocarditis analyzed by CIBERSORT. J Cardiol. 2021 Feb;77(2):174-178. doi:10.1016/j.jjcc.2020.08.004.
28. 渡邉昌俊、山口智彦. 今、数理が面白いー医学・生物学への応用. 医学のあゆみ, 279(3), 181, 2021
2020
1. Yamamoto N, Eguchi A, Hirokawa Y, Ogura S, Sugimoto K, Iwase M, Watanabe M, Takei Y. Expression pattern of PLXDC2 in human hepatocellular carcinoma. Monoclon Antib Immunodiagn Immunother. 39(2), 57-60, 2020.
2. Mahmud MRA, Ishii K, Bernal-Lozao C, Delgado-Sainz I, Toi M, Akamatsu S, Fukumoto M, Watanabe M, Takeda S, Cortes-Ledesma F, Sasanuma H. TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands. Genes to Cells, 00, 1-16, 2020.
3. Sonoda Y, Sasaki Y, Gunji A, Shirai H, Araki T, Imamichi S, Onodera T, Rydén A-M, Watanabe M, Itami J, Honda T, Ashizawa K, Nakao K, Masutani M. Reduced tumorigenicity of mouse ES cells and the augmented anti-tumor therapeutic effects under Parg deficiency. Cancers, 12(4), 1056, 2020.
4. Mizutani K, Shirakami E, Ichishi M, Matsushima Y, Umaoka A, Okada K, Yamaguchi Y, Watanabe M, Morita E, Yamanaka K. Long-lasting severe dermatitis affect visceral adipose tissue via skin-derived inflammatory cytokines. Int J Med Sci, 21, 3367, 2020.
5. Kanayama K, Imai H, Usugi E, Matsuda C, Ichishi M, Hirokawa YS, Watanabe M
Cancer-related gene mutations and intratumoral genetic heterogeneity in human epidermal growth factor receptor 2 heterogeneous gastric cancer
Pathol Int, 70(11), 865-870, 2020.
6. Hirokawa Y, Kanayama K, Kagaya M, Shimojo N, Uchida K, Imai H, Ishii K, Watanabe M. SOX11-induced decrease in vimentin and an increase in prostate cancer cell migration attributed to cofilin activity. Exp Mol Pathol. 117:104542. 2020.
7. Sawada Y, Nakai Y, Yokota N, Habe K, Hayashi A, Yamanaka K. Voriconazole-Induced Squamous Cell Carcinoma after Hematopoietic Stem Cell Transplantation Showing Early-Stage Vascular Invasion. Dermatopathology. 7(3):48-52. 2020.
8. Wakai E, Suzumura Y, Ikemura K, Mizuno T, Watanabe M, Takeuchi K, Nishimura Y. An integrated in silico and in vivo approach identifies protective effects of palonosetron in cisplatin-induced nephrotoxicity. Pharmaceuticals, 13,480, 2020.
9. Asanuma K, Nakamura T, Hayashi A, Okamoto T, Iino T, Asanuma Y, Hagi T, Kita K, Nakamura K, Sudo A. Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas. Sci Rep. 10(1):9077. 2020
10. Katoh D, Kozuka Y, Noro A, Ogawa T, Imanaka-Yoshida K, Yoshida T. Tenascin-C Induces Phenotypic Changes in Fibroblasts to Myofibroblasts with High Contractility through the Integrin αvβ1/Transforming Growth Factor β/SMAD
Signaling Axis in Human Breast Cancer. Am J Pathol. 2020 Oct;190(10):2123-2135. doi: 10.1016/j.ajpath.2020.06.008.
11. Sugie T, Sato E, Miyashita M, Yamaguchi R, Sakatani T, Kozuka Y, Moritani S, Suzuki E, Kakimi K, Mikami Y, Moriya T. Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer. Breast Cancer. 2020 Jul;27(4):519-526. doi: 10.1007/s12282-020-01110-2.
12. Ito T, Kuriyama N, Kozuka Y, Komatsubara H, Ichikawa K, Noguchi D, Hayasaki A, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S. High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection. BMC Cancer. 2020 Mar 12;20(1):209. doi: 10.1186/s12885-020-6695-9.
2019
1. Ishii K, Sasaki T, Iguchi K, Kato M, Kanda H, Hirokawa Y, Arima K, Watanabe M, Sugimura Y. Pirfenidone, an anti-fibrotic drug, suppresses the growth of human prostate cancer cells by inducing G1 cell cycle arrest. J Clin Med, 8(1), 44, 2019.
2. Sasaki T, Franco OE, Ohishi K, Ishii K, Crawford SE, Takahashi N, Katayama N, Sugimura Y, Hayward SW. Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patients. Prostate. 79(3), 259-264, 2019.
3. Usugi E, Ishii K, Hirokawa Y, Kanayama K, Matsuda C, Uchida K, Shiraishi T, Watanabe M. Anti-fibrotic agent pirfenidone suppresses proliferation of human pancreatic cancer cells by inducing G0/G1 cell cycle arrest. Pharmacology. 103(5-6), 250-256. 2019.
4. Kanayama K, Imai H, Usugi E, Shiraishi T, Hirokawa YS, Watanabe M. Letter to editor: reply to Antonio Ieni "Intratumoral HER2 heterogeneity in early gastric carcinomas: potential bias in therapeutical management". Virchows Arch. 474(3), 403-404, 2019.
5. Ishii K, Matsuoka I, Sasaki T, Nishikawa K, Kanda H, Imai H, Hirokawa Y, Iguchi K, Arima K, Sugimura Y. Loss of fibroblast-dependent androgen receptor activation in prostate cancer cells is involved in the mechanism of acquired resistance to castration. J Clin Med. 8(9), E1379, 2019.
6. 石井健一朗, 前立腺がん治療反応性に関わる線維芽細胞の多様性, 医学のあゆみ, 270 (12), 1125-1131, 2019.
7. Kajiwara S, Ishii K, Sasaki T, Kato M, Nishikawa K, Kanda H, Arima K, Watanabe M, Sugimura Y. Castration-induced stromal remodeling disrupts the reconstituted prostate epithelial structure. Laboratory Investigation (in press)
8. Ishii K. Cytobiology of human prostate cancer cells and its clinical applications. J Clin Med. 8(10), E1716, 2019.
9. Endo M, Katayama K, Matsuo H, Horiike S, Nomura S, Hayashi A, Ishikawa E, Harada T, Sugimoto R, Tanemura A, Sugimoto K, Isaji S, Ito M. Role of Liver Transplantation in Tolvaptan-Associated Acute Liver Failure. Kidney Int Rep. 4(11):1653-1657. 2019.
10. Nakamura A, Tawara I, Ino K, Matsumoto T, Hayashi A, Imai H, Muraosa Y, Kamei K, Katayama N. Achievement of long-term remission of disseminated histoplasmosis in an AIDS patient. Med Mycol Case Rep. 27:25-28. 2019.
11. Matsushima Y, Hayashi A, Mizutani K, Kondo M, Nakai Y, Habe K, Yamaguchi Y, Kozuka Y, Wakabayashi H, Yamanaka K. Psoriasiform Dermatitis Developing during Treatment of Juvenile Idiopathic Arthritis with Tocilizumab. Case Rep Dermatol. 11:317–321, 2019.
12. Tanaka F, Matsukawa M, Kogue R, Umino M, Maeda M, Uchida K, Imai H, Matsubara T, Sakuma H. A case of a rosette-forming glioneuronal tumor arising from the pons withdisappearance of contrast enhancement. Radiol Case Rep. 14(8):899-902. 2019.
13. Hayasaki A, Murata Y, Usui M, Hibi T, Fujii T, Iizawa Y, Kato H, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Uchida K, Isaji S. Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes. Biomed Res Int. doi: 10.1155/2019/5738614. 2019.
14. Hattori T, Matsumine A, Uchida K, Nojima T, Sudo A. Benign Fibrous Histiocytoma of the Talus: A Case Report. J Foot Ankle Surg. 58(4):762-765. 2019.
2018
1. Kanayama K, Imai H, Usugi E, Shiraishi T, Hirokawa YS, Watanabe M. Association of HER2 gene amplification and tumor progression in early gastric cancer. Virchows Arch. 473(5):559-565, 2018.
2. Kojima K, Takahashi S, Saito S, Endo Y, Nittami T, Nozaki T, Sobti RC, Watanabe M. Combined effects of Fe3O4 nanoparticles and chemotherapeutic agents on prostate cancer cells in vitro. Applied Sciences, 8(1), 134, 2018.
3. Fukai E, Sato H, Watanabe M, Nakae D, Tostuka Y. Establishment of an in vivo simulating co-culture assay platform for genotoxicity of multi-walled carbon nanotubes. Cancer Sci, 109(4), 1024-1031, 2018.
4. Ishii K, Takahashi S, Sugimura Y, Watanabe M. Role of stromal paracrine signals in proliferative diseases of the aging human prostate. J. Clin. Med., 7(4), 68, 2018.
5. Lee GW, Park JB, Park SY, Seo J, Shin SH, Park JW, Kim SJ, Watanabe M, Chun YS. The E3 ligase C-CBL inhibits cancer cell migration by neddylating the proto-oncogene c-Src. Oncogene, 37(41), 5552-5568, 2018.
6. Fujiwara Y, Nishida M, Saito M, Robles AI, Takeshita F, Watanabe M, Ochiya T, Yokota J, Kohno T, Harris CC, Tsuchiya N. A nucleolar stress–specific p53–miR-101 molecular circuit functions as an intrinsic tumor-suppressor network. EBioMedicine, 33, 33-48, 2018.
7. Kudo Y, Sasaki Y, Onodera T, Hashimoto J, Nozaki T, Tamura K, Watanabe M, Masutani M. Measurement of poly(ADP-ribose) level with enhanced slot blot assay with crosslinking. Challenges 9(2), 27, 2018
8. Hayashi K, Yamada S, Sakamoto W, Usugi E, Watanabe M, Yogo T. Red Blood Cell-Shaped Microparticles with Red Blood Cell Membrane Demonstrate Prolonged Circulation Time in Blood. ACS Biomaterials Sci. Eng. 4(8), 2729-2732, 2018.
9. Miki M, Ishii K, Sasaki T, Kato M, Kajiwara S, Kanda H, Arima K, Hirokawa Y, Watanabe M, Sugimura Y. Predicting the tumorigenic phenotype of human bladder cancer cells by combining with fetal rat mesenchyme. Urol. Oncol. 36(10), 472.e1-472.e9, 2018.
10. Ishii K, Sasaki T, Iguchi K, Kajiwara S, Kato M, Kanda H, Hirokawa Y, Arima K, Mizokami A, Sugimura Y. Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation. Prostate, 78: 849-856, 2018.
11. Ishii K, Matsuoka I, Kajiwara S, Sasaki T, Miki M, Kato M, Kanda H, Arima K, Shiraishi T, Sugimura Y. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells. J Cancer Res Clin Oncol, 144(1) 89-98, 2018.
12. Nakaguro M, Urano M, Suzuki H, Yamada K, Sakaguchi A, Ogura K, Matsumoto T, Ono N, Asato T, Mikami Y, Imai H, Nagao T. Low-grade intraductal carcinoma of the salivary gland with prominent oncocytic change: a newly described variant. Histopathology, 73(2), 314-320. 2018.
13. Imai N, Kitayama M, Shibahara A, Bessho Y, Shibusawa M, Noro A, Inakami K, Hanamura N, Imai H, Ogawa T. Strategy for the accurate preoperative evaluation of the number of metastatic axillary lymph nodes in breast cancer. Asian J Surg. 2018 Apr 13. pii: S1015-9584(17)30571-7. doi: 10.1016/j.asjsur.2018.03.003.
14. Mizoguchi S, Katayama K, Murata T, Ishikawa E, Kozuka Y, Honda Y, Oda K, Hirabayashi Y, Ito T, Ito M. IgM-Positive Tubulointerstitial Nephritis Associated With Asymptomatic Primary Biliary Cirrhosis. Kidney Int Rep. 3(4), 1004-1009, 2018.
15. Ueno N, Kuroda H, Kurosumi M, Kozuka Y, Ito J, Kato H, Kubota K, Imai Y. Clinicopathological study of a dimorphic variant of breast carcinoma. Breast Cancer. 25(2):151-158, 2018.
16. 内田克典, 現代のグリソン分類とISUPグレードグループ分類. 腎臓内科・泌尿器科. 7, 256-62, 2018.
17. 湯淺博登, 萩原仁美, 藤田祐一, 臼井美希, 馬場洋一郎, 村田哲也, 渡邉昌俊. 鼻腔に生じた鼻硬化腫の1例. 診断病理. 35(3), 206-9, 2018.
18. 石井健一朗, 佐々木豪, 渡邉昌俊, 杉村芳樹. リガンド非依存的なアンドロゲン受容体活性化機構の多様性から考える前立腺癌治療の課題と展望. 泌尿器外科, 31 (8), 1123-1125, 2018.
19. 小塚祐司, 湯淺博登, 渡邉昌俊. 結合織性および上皮混合性腫瘍, 非上皮性腫瘍, その他病変. 病理と臨床, 36(9), 894-902, 2018.
20. Nishimura Y, Kasahara K, Shiromizu T, Watanabe M, Inagaki M. Primary cilia as signaling hubs in health and disease. Adv. Sci. 1801138, 2018
21. Kurihara K, Toyoda H, Amoano K, Inoue M, Uchida K, Sakurai H, Hayashi A, Hirayama M. Discontinuation of NTBC after liver transplantation in tyrosinemia type 1. Pediatr Int. 60(11), 1039-1041, 2018
22. Murata Y, Ando K, Usui M, Sugiyama H, Hayashi A, Tanemura A, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Isaji S. A case of hepatic anisakiasis caused by Pseudoterranova decipiens mimicking metastatic liver cancer. BMC Infect Dis. 18:619, 2018
23. Onishi T, Sekito S, Shibahara T, Uchida K, Sasaki T. The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer. Scand J Urol. 52(5-6):385-388. 2018.
2017
1. Amemiya T, Shibata K, Itoh Y, Itoh K, Watanabe M, Yamaguchi T. Primordial oscillations in life: Direct observantion of glycolytic oscillations in individual HeLa cervical cancer cells. Chaos. 2017 Oct; 27(10): 104602.
2. Kato T, Toyooka T, Ibuki Y, Masuda S, Watanabe M, Totsuka Y. Effects of physicochemical character differences on the genotoxic potency of kaolin. Genes Environ. 2017 May 1;39:12.
3. Shimojo N, Hirokawa YS, Kanayama K, Yoneda M, Hashizume R, Hayashi A, Uchida K, Imai H, Kozuka Y, Shiraishi T. Cytological features of adenocarcinoma admixed with small cell neuroendocrine carcinoma of the uterine cervix. Cytojournal. 2017 May 26;14:12.
4. Iwamoto Y, Ishii K, Kanda H, Kato M, Miki M, Kajiwara S, Arima K, Shiraishi T, Sugimura Y. Combination treatment with naftopidil increases the efficacy of radiotherapy in PC-3 human prostate cancer cells. J Cancer Res Clin Oncol, 143(6), 933-939, 2017.
5. Takeuchi T, Yamaguchi M, Kobayashi K, Miyazaki K, Tawara I, Imai H, Ono R, Nosaka T, Tanaka K, Katayama N. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma. 23(7), 1166-1173, Cancer. 2017.
6. Kawasaki T, Saito T, Uchida K, Mio K, Nishida H, Homma K. A case of mucin-producing urothelial-type adenocarcinoma of the prostate showing immunoreactivity for NKX3.1, a specific marker of prostatic tissue. Pathol Int, 67(9), 483-484, 2017
7. Sakaida H, Yuasa H, Fukutome K, Takeuchi K. Pharyngolaryngeal ulcers associated with the improper use of alendronate. Auris Nasus Larynx. 44(6), 762-5, 2017.
8. 内田克典, 森尾邦正, 栗山直久, 臼井正信, 伊佐地秀司. 胆道癌に対する術前治療後の病理組織学的効果判定法. 胆と膵. 38(5), 433-7, 2017.
9. 松島由明, 波部幸司, 山中恵一, 水谷仁, 今井裕, 渡邉昌俊. Primary cutaneous myxoid spindle cell squamous cell carcinoma. 皮膚病診療. 9, 949-52, 2017.
10. 石井健一朗, 杉村 芳樹. 前立腺肥大結節の発生・進展における上皮－間質相互作用, Prostate Journal, 4 (1): 105-114, 2017.